Accounts Payable, Current in USD of Immunovant, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Immunovant, Inc. quarterly Accounts Payable, Current history and change rate from Q1 2019 to Q3 2025.
  • Immunovant, Inc. Accounts Payable, Current for the quarter ending September 30, 2025 was $6.92M, a 66.6% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.92M -$13.8M -66.6% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $7.84M -$3.19M -28.9% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $17.7M +$10.5M +147% Mar 31, 2025 10-Q 2025-11-10
Q4 2024 $19.8M +$15.9M +407% Dec 31, 2024 10-Q 2025-02-06
Q3 2024 $20.7M +$13.2M +176% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11M -$15.4M -58.3% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.16M +$5.8M +429% Mar 31, 2024 10-K 2025-05-29
Q4 2023 $3.91M -$10.1M -72.1% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $7.51M +$50K +0.67% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $26.5M +$25.4M +2382% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.35M -$17.3M -92.7% Mar 31, 2023 10-K 2024-05-29
Q4 2022 $14M +$10.2M +266% Dec 31, 2022 10-Q 2023-02-03
Q3 2022 $7.46M +$3.22M +75.8% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.07M -$2.04M -65.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $18.6M +$16.2M +666% Mar 31, 2022 10-K 2023-05-22
Q4 2021 $3.83M +$1.73M +82.2% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 $4.24M -$1.54M -26.7% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $3.11M -$4.9M -61.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.43M +$1.24M +104% Mar 31, 2021 10-K 2022-06-08
Q4 2020 $2.1M -$712K -25.3% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $5.79M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $8.01M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.19M +$984K +478% Mar 31, 2020 10-K 2021-06-01
Q4 2019 $2.81M Dec 31, 2019 10-Q 2020-02-14
Q1 2019 $206K Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.